BRIDGEWATER, N.J., May 10 /PRNewswire-FirstCall/ -- Sanofi-aventis, the world's third largest pharmaceutical company, announced today that it has entered into a long-term lease with BioMed Realty Trust in Cambridge, MA, to accommodate a significant expansion of its research and development facility.
Over the last decade, Cambridge has become one of the most important biotech centers in the world. "This expansion coupled with the emerging innovative technology from the quality universities that surround us, will help sanofi-aventis to meet its ambitious research and development goals while operating in the very heart of this biotech hub," according to Porter McMillian, Senior Vice President, U.S. Science & Medical Affairs for sanofi-aventis,
Sanofi-aventis will be moving all of its employees from the current location at 26 Landsdowne Street into a larger facility at 270 Albany Street. Jason Slusher, Director of Operations, U.S. Science & Medical Affairs for the Cambridge Genomics Center of sanofi-aventis states, "Our goal is to continue recruiting and employing the most talented researchers in the world. This culturally rich and diverse city is an ideal place to work and raise a family." Financial details of the agreement were not disclosed.
The building's size is approximately 73,000 square feet, more than twice the space at the current facility. Occupancy is expected in the second quarter of 2007, following interior renovations.
About sanofi-aventis
Sanofi-aventis is the world's third largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi-aventis is listed in Paris and in New York .
Media Contacts:
Gina DeSalvo-Tilton: 908-921-3968
Marc Greene: 212-551-4400
Sanofi-aventisCONTACT: Gina DeSalvo-Tilton, +1-908-921-3968, or Marc Greene,+1-212-551-4400, both of Sanofi-aventis
Web site: http://www.sanofi-aventis.com/
Company News On-Call: http://www.prnewswire.com/comp/232375.html /
